A microtubule-stabilizing antineoplastic compound used in cell-cycle and apoptosis research.
Paclitaxel is a naturally occurring antineoplastic compound that stabilizes microtubule polymerization and disrupts normal microtubule dynamics. It is commonly used to induce mitotic arrest and investigate cell-cycle regulation, apoptosis, autophagy and resistance to anticancer compounds.
Manufacturer: MedChemExpress (MCE)
Catalog number: HY-B0015
CAS number: 33069-62-4
Molecular formula: C47H51NO14
Molecular weight: 853.91
Primary target: Microtubule/tubulin
Research areas: Cell cycle, apoptosis, oncology and drug resistance
Available sizes: Multiple pack sizes available
Purity: Refer to the current lot-specific COA
Research use only: Not for human or veterinary use
Original product link: MCE Paclitaxel product page
Contact Biolterna for current availability, COA documentation or related microtubule-targeting compounds.
